Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-12 Sale | 2024-08-13 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 98,943 | $17.3 | $1,711,447 | 0 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:20 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 48,629 | $13.52 | $657,240 | 121,519 (Direct) | View |
| 2024-03-04 Sale | 2024-03-05 4:21 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 95,762 | $13.34 | $1,277,207 | 405,392 (Direct) | View |
| 2024-02-28 Sale | 2024-03-01 06:43 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 20,599 | $13.12 | $270,176 | 69,770 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 72,009 | $9.5536 | $687,949 | 69,770 (Direct) | View |
| 2023-02-28 Sale | 2023-03-02 07:33 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 44,252 | $9.8866 | $437,502 | 90,369 (Direct) | View |
| 2022-03-04 Sale | 2022-03-08 4:03 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 58,952 | $7.4382 | $438,494 | 260,879 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 07:41 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 20,598 | $8.1422 | $167,713 | 61,477 (Direct) | View |
| 2022-02-09 Sale | 2022-02-10 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 13,135 | $9.0605 | $119,010 | 63,638 (Direct) | View |
| 2021-03-04 Sale | 2021-03-08 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 7,513 | $10.58 | $79,521 | 142,425 (Direct) | View |
| 2021-03-03 Sale | 2021-03-04 4:01 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 993 | $10.88 | $10,803 | 11,873 (Direct) | View |
| 2021-03-01 Sale | 2021-03-02 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 20,598 | $10.85 | $223,507 | 72,560 (Direct) | View |
| 2021-02-09 Sale | 2021-02-11 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 68,422 | $12.72 | $870,389 | 23,900 (Direct) | View |
| 2020-09-09 Sale | 2020-09-10 09:04 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 333 | $8.9844 | $2,992 | 10,765 (Direct) | View |
| 2020-03-17 Sale | 2020-03-19 07:31 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 616 | $7.1714 | $4,418 | 10,400 (Direct) | View |
| 2020-03-03 Sale | 2020-03-05 08:07 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 991 | $11.77 | $11,660 | 11,820 (Direct) | View |
| 2020-02-10 Sale | 2020-02-11 06:52 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 6,199 | $12.24 | $75,886 | 34,882 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-05 Exercise | 2024-03-07 4:20 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 77,802 | $0 | 121,519 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:21 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 81,845 | $0 | 405,392 (Direct) | View |
| 2024-03-03 Exercise | 2024-03-05 4:21 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 95,762 | $0 | 405,392 (Direct) | View |
| 2024-02-28 Exercise | 2024-03-01 06:43 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 20,599 | $0 | 69,770 (Direct) | View |
| 2024-01-30 Option Award | 2024-02-01 07:28 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 55,226 | $0 | 55,226 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-07 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 249,003 | $0 | 536,470 (Direct) | View |
| 2023-03-04 Exercise | 2023-03-07 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 72,009 | $0 | 536,470 (Direct) | View |
| 2023-02-28 Exercise | 2023-03-02 07:33 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 70,840 | $0 | 90,369 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 07:01 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 50,242 | $0 | 50,242 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 134,048 | $0 | 260,879 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 81,854 | $0 | 260,879 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-02 07:41 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 20,598 | $0 | 61,477 (Direct) | View |
| 2022-02-08 Option Award | 2022-02-10 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 43,358 | $0 | 63,638 (Direct) | View |
| 2022-02-09 Exercise | 2022-02-10 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 13,135 | $0 | 63,638 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-08 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 90,304 | $0 | 142,425 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-08 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 15,920 | $0 | 142,425 (Direct) | View |
| 2021-03-03 Exercise | 2021-03-04 4:01 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 2,101 | $0 | 11,873 (Direct) | View |
| 2021-02-28 Exercise | 2021-03-02 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 20,598 | $0 | 72,560 (Direct) | View |
| 2021-02-09 Option Award | 2021-02-11 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 55,287 | $0 | 23,900 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 13,135 | $0 | 23,900 (Direct) | View |
| 2020-09-09 Exercise | 2020-09-10 09:04 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 698 | $0 | 10,765 (Direct) | View |
| 2020-03-17 Exercise | 2020-03-19 07:31 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 1,297 | $0 | 10,400 (Direct) | View |
| 2020-03-03 Exercise | 2020-03-05 08:07 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 2,098 | $0 | 11,820 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 07:06 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 82,393 | $0 | 82,393 (Direct) | View |
| 2020-02-09 Exercise | 2020-02-11 06:52 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 13,135 | $0 | 34,882 (Direct) | View |